B cells and tertiary lymphoid structures promote immunotherapy response

Journal: Nature

Published: 2020-01-15

DOI: 10.1038/s41586-019-1922-8

Affiliations: 27

Authors: 60

Go to article
Institutions Share
The University of Texas MD Anderson Cancer Center, United States of America (USA) 0.70
Netherlands Cancer Institute (NKI), Netherlands 0.10
NanoString Technologies, Inc., United States of America (USA) 0.05
Cordelier Research Center (CRC), France 0.04
Massachusetts General Hospital (MGH), United States of America (USA) 0.04
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.02
Immunology Program, MSKCC, United States of America (USA) 0.02
Health Sciences, Pitt, United States of America (USA) 0.02
Broad Institute of MIT and Harvard, United States of America (USA) 0.01
Ligue Contre Le Cancer, France 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER